Sahil Mathur

Sahil Mathur

Active Director Director DIN 05139027
DIN 05139027 First appointment Dec 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2011
Shareholding value •••• Premium profile

About Sahil Mathur

Data last updated:

Sahil Mathur is a Director at Jyke Pharmaceutical Private Limited (since 2011). The company operates in Pharma. Jyke Pharmaceutical Private Limited reported revenue of ₹1.31 Cr (FY 2025).

DIN 05139027
Primary Designation Director
Industry Pharma
First Appointment 12 Dec 2011
Oldest Company Age 14 yrs
Largest company Jyke Pharmaceutical Private Limited · ₹1.31 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jyke Pharmaceutical Private Limited U24232MP2011PTC027280
Director12 Dec 20112011₹1.31 Cr (FY 2025)Active

Board colleagues of Sahil Mathur

Directorship timeline

Open interactive timeline →
Jyke Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sahil Mathur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sahil Mathur

Sahil Mathur currently holds 1 directorship: Jyke Pharmaceutical Private Limited (Director, since 12 Dec 2011, revenue ₹1.31 Cr (FY 2025)).

Sahil Mathur was first appointed on 12 Dec 2011 as Director at Jyke Pharmaceutical Private Limited.

The current boards of Sahil Mathur's companies include Jai Prakash Mathur (Jyke Pharmaceutical Private Limited), Satyendra Kumar Jain (Jyke Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available